Feasibility of Intratumoral Anti-PD1 as Treatment of Human Basal Cell Carcinoma: An Explorative Study with Adjuvant Ablative Fractional LaserSilje Haukali Omland, Merete Hædersdal|Cancers|2022Cited by 13